Clinical Trials Logo

Distal Myopathy, Nonaka Type clinical trials

View clinical trials related to Distal Myopathy, Nonaka Type.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02377921 Completed - GNE Myopathy Clinical Trials

Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

GNEM
Start date: May 20, 2015
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the effect of 6 g/day aceneuramic acid extended-release (Ace-ER) treatment of participants with GNEM on upper extremity muscle strength (upper extremity composite [UEC] score) as measured by dynamometry.